# TENAX THERAPEUTICS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:fb4d11a6-5662-4530-9ef2-178ba713f404 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/tenax-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:59.013572+00:00 | | Last reviewed | 2026-10-17T04:46:59.013572+00:00 | ## Identity - Legal name: TENAX THERAPEUTICS, INC. - Display name: TENAX THERAPEUTICS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T05:56:22.497871+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 7 | | Committees | 2 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Christopher T. Giordano: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:5 - Declan Doogan, MD: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:6 - Gerald T. Proehl: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:7 - June Almenoff, MD, PhD: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:8 - Michael Davidson, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:9 - Robyn M. Hunter: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:10 - Stuart Rich, MD: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:11 ## Committees - Compensation (compensation). Chair: Gerald T. Proehl. Members: Gerald T. Proehl (chair, current); Michael Davidson, M.D. (member, current); Robyn M. Hunter (member, current). committee_id=alpha:committee:tenax-therapeutics-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Gerald T. Proehl (member, current). committee_id=alpha:committee:tenax-therapeutics-inc:compensation-chair ## Executive leadership - Christopher T. Giordano: President and Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:12 - Stuart Rich: Chief Medical Officer and Director. Status: current. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:13 - Thomas A. McGauley: Interim Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:14 ## Governance events - CEO_CHANGED: Christopher T. Giordano executive of TENAX THERAPEUTICS, INC., effective 2026-03-10. Effective: 2026-03-10. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:12lp8m11dvke5z - EXECUTIVE_APPOINTED: Stuart Rich executive of TENAX THERAPEUTICS, INC., effective 2026-03-10. Effective: 2026-03-10. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:2ufk8zyei3gt - CFO_CHANGED: Thomas A. McGauley executive of TENAX THERAPEUTICS, INC., effective 2026-03-10. Effective: 2026-03-10. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:11hg3x0w50vik - DIRECTOR_APPOINTED: Robyn M. Hunter seat on TENAX THERAPEUTICS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1w13s343q48ca - DIRECTOR_APPOINTED: Christopher T. Giordano seat on TENAX THERAPEUTICS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:17f0r511qbrybl - DIRECTOR_APPOINTED: Declan Doogan, MD seat on TENAX THERAPEUTICS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:8vkfok143rs66 - DIRECTOR_APPOINTED: June Almenoff, MD, PhD seat on TENAX THERAPEUTICS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1c55yiy12p9vw0 - DIRECTOR_APPOINTED: Michael Davidson, M.D. seat on TENAX THERAPEUTICS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:u6klw1h8ptl9 - DIRECTOR_APPOINTED: Stuart Rich, MD seat on TENAX THERAPEUTICS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:3x15ck1tz25u4 - COMMITTEE_MEMBER_ADDED: Michael Davidson, M.D. member of Compensation, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:6tt3i1ivhtf9 - DIRECTOR_APPOINTED: Gerald T. Proehl seat on TENAX THERAPEUTICS, INC., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1o3172p2uypd1 - COMMITTEE_CREATED: Compensation · Chair committee of TENAX THERAPEUTICS, INC., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:aq7xkf189babd - COMMITTEE_MEMBER_ADDED: Gerald T. Proehl member of Compensation · Chair, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:46:59.013572+00:00. event_id=alpha:event:transition:1m16698acdgqo ## Scoped resources - `alpha://company/tenax-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record - `alpha://company/tenax-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=identity - `alpha://company/tenax-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/tenax-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=board - `alpha://company/tenax-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=committees - `alpha://company/tenax-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=leadership - `alpha://company/tenax-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=ownership - `alpha://company/tenax-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=financials - `alpha://company/tenax-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/tenax-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=compensation - `alpha://company/tenax-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=governance - `alpha://company/tenax-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/tenax-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=audit - `alpha://company/tenax-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=legal - `alpha://company/tenax-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=risk - `alpha://company/tenax-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=cyber - `alpha://company/tenax-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/tenax-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=agents - `alpha://company/tenax-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/tenax-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=events - `alpha://company/tenax-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=relationships - `alpha://company/tenax-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=assessments - `alpha://company/tenax-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:gerald-t-proehl","name":"Gerald T. Proehl"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-davidson-md","name":"Michael Davidson, M.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:robyn-m-hunter","name":"Robyn M. Hunter"},"source_id":"board_seats"}` ## Leadership - Christopher T. Giordano: Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Declan Doogan, MD: Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Gerald T. Proehl: Director, Compensation · Chair. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - June Almenoff, MD, PhD: Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Michael Davidson, M.D.: Director, Compensation. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Robyn M. Hunter: Director, Compensation. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:10. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Stuart Rich, MD: Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7. - Christopher T. Giordano: President and Chief Executive Officer and Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:12. Valid from: 2026-03-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b0fd8d745611cb3764f39f7fd0893cacc4cddb6782705233b8b566d7bd6510ae. - Stuart Rich: Chief Medical Officer and Director. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:13. Valid from: 2026-03-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7cffe1dccff1c71b676d244ddb2d986805013c730681d7675b928827976ee131. - Thomas A. McGauley: Interim Chief Financial Officer. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:leadership_role:14. Valid from: 2026-03-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e1a9cff4326c50ed3ab9ce652f2e621fa9f72a22e43a0a0eb5008a3e26d5b0c3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Compensation: Chair Gerald T. Proehl; Members Gerald T. Proehl (Chair); Michael Davidson, M.D.; Robyn M. Hunter. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:81a31d07cc1b9b03554b4703ef60a8944d7187250bf15c832995f89789cefd1a. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - TENAX THERAPEUTICS, INC.. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:019738e0088d899ea33c6bff9cc88abab07dc77ea50942cf8e3d040e7a2e6492. ## Entity Status - Public listing published. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:019738e0088d899ea33c6bff9cc88abab07dc77ea50942cf8e3d040e7a2e6492. ## Published Fact - US. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:019738e0088d899ea33c6bff9cc88abab07dc77ea50942cf8e3d040e7a2e6492. ## Committee Appointment - Gerald T. Proehl: chair, Compensation. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:81a31d07cc1b9b03554b4703ef60a8944d7187250bf15c832995f89789cefd1a. - Michael Davidson, M.D.: member, Compensation. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:81a31d07cc1b9b03554b4703ef60a8944d7187250bf15c832995f89789cefd1a. - Robyn M. Hunter: member, Compensation. Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:81a31d07cc1b9b03554b4703ef60a8944d7187250bf15c832995f89789cefd1a. ## Security Listing - TENX (NASDAQ). Claim: alpha:claim:company:fb4d11a6-5662-4530-9ef2-178ba713f404:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:019738e0088d899ea33c6bff9cc88abab07dc77ea50942cf8e3d040e7a2e6492. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:019738e0088d899ea33c6bff9cc88abab07dc77ea50942cf8e3d040e7a2e6492: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/tenax-therapeutics-inc). - alpha:projection-evidence:document:7b440c5137765687947034c5514a137e605babeece2fff47d8fb35709be9b7c7: [TENAX THERAPEUTICS, INC. DEF 14A 2026-04-22](https://www.sec.gov/Archives/edgar/data/34956/000119312526168580/tennx-20260417.htm). - alpha:projection-evidence:document:b0fd8d745611cb3764f39f7fd0893cacc4cddb6782705233b8b566d7bd6510ae: [TENX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/tennx-20251231.htm). - alpha:projection-evidence:document:7cffe1dccff1c71b676d244ddb2d986805013c730681d7675b928827976ee131: [TENX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/tennx-20251231.htm). - alpha:projection-evidence:document:e1a9cff4326c50ed3ab9ce652f2e621fa9f72a22e43a0a0eb5008a3e26d5b0c3: [TENX 10-K executive officers](https://www.sec.gov/Archives/edgar/data/34956/000119312526099393/tennx-20251231.htm). - alpha:projection-evidence:81a31d07cc1b9b03554b4703ef60a8944d7187250bf15c832995f89789cefd1a: [Compensation](https://www.sec.gov/Archives/edgar/data/34956/000119312526168580/tennx-20260417.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/tenax-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/tenax-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/tenax-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/tenax-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T05:56:22.21914+00:00; recorded 2026-10-17T05:56:22.21914+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.